Star of 'An American In Paris' on Musical's Revival
*By Bridgette Webb*
Musical theater is coming back to the big screen with a production of the Tony Award-winning musical "An American in Paris."
Robert Fairchild, who stars as the titular American alongside Leanne Cope, said it's all about the visuals.
"It's thrilling, we have the gorgeous show, and it's finally being allowed to be shown around the country," Fairchild said Thursday in an interview on Cheddar.
The story is based off the 1951 Oscar-winning film, which featured glitzy performances from Hollywood legends Gene Kelly and Leslie Caron. That movie was adapted into a musical that won four Tonys in 2015. The latest rendition was recorded during stage performances in London.
Translating a performance from theater to film is a risk, as the expectations for stage and screen are starkly different, but Fairchild thinks filmmakers were successful.
"They captured the show so brilliantly," he said. "It looks, at times, like you are at a Broadway show."
But he still holds the original film in high esteem.
"There's no way you can compare with Leslie Caron and Gene Kelly," he said. "They're such stars, and they are unbelievably gorgeous. You can't redo something that is perfect."
"An American in Paris" will be shown in select theaters in the U.S. and Canada on September 20 and 23.
For full interview [click here](https://cheddar.com/videos/an-american-in-paris-from-the-stage-to-the-screen).
Sandra Magallon, Midwest Divison Area Manager at JPMorgan Chase, joins ChedHER to discuss the perks of having a business mentor, and what business owners can learn from Chase's Curated Coaching for Entrepreneurs experience.
Sarah Kellogg Neff, CEO of The Lactation Network, joins ChedHER to discuss how they are expanding access to lactation support for families nationwide, and some of the struggles new families face during the fourth trimester.
Award-winning journalist, entrepreneur, and host Soledad O'Brien spoke to Cheddar about empowering women through her own podcast on financial literacy this Women's History Month.
President Bident talks to President Xi about Ukraine, rising COVID cases in Europe have U.S. officials concerned, and a deal is putting DoorDash against actual Girl Scouts for GS cookie sales. Here is all the news you Need2Know for Friday. March 18, 2022.
March Nadness is officially underway, and betting on this year's tournament has the potential to reach record levels. About 45 million Americans are expected to wager a total of $3.1 billion on just the men's tournament alone, according to a new survey from the American Gaming Association. Prince Grimes, Senior Writer for USA Today's sports betting media property, BetFTW, joins Cheddar News' Closing Bell to discuss how betting could play into this year's tournament and other storylines surrounding March Madness.
Medical cannabis company Akanda went public this week in what was the first traditional IPO of the month. Shares jumped about 163% in the stock's first day of trading. The London-based company says it hopes to supply medical cannabis products to wholesalers in international markets. Tej Virk, CEO of Akanda, joins Cheddar News' Closing Bell to discuss.
Software company Akeneo CEO Fred De Gombert joined Closing Bell to discuss its recently closed Series D funding round raising $135 million in its quest to redefine product information management. De Gombert said the company is set out to improve the product information category by harnessing the power of data, which comes at a time where customer behavior has shifted in the pandemic era. "We are more and more demanding as consumers when we are shopping online or even offline. We are looking for more and more information," De Gombert said.
Sara Bareilles and Busy Philipps join Cheddar News at South by Southwest in Austin, Texas. The two actors talk all about their Peacock comedy series 'Girls5eva.'
Bioscience and genetic engineering company, Colossal, raised $60 million in a Series A funding round. Colossal is focused on developing new technologies and genetic tools to restore extinct species, and protect critically endangered species. One of the startup's long-term goals is to resurrect the woolly mammoth, and return it back to the arctic. Colossal also says it is developing technology that expands beyond animals, and has the potential to advance human health. Ben Lamm, co-founder and CEO of Colossal, joins Cheddar News' Closing Bell to discuss.
